Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Pharmaceutical Executive: August 2025 Interactive Digital Edition

Articles in this issue

Trending on PharmExec

Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata

Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio

Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI

U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report

Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg